Novel mitochondria-to-lysosome crosstalk contributes to lysosomal dysfunction during aging

新型线粒体与溶酶体串扰导致衰老过程中溶酶体功能障碍

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT Aging is accompanied by the gradual deterioration within each individual cellular compartments/organelles as well as the collapse of the interconnections among them, leading to the establishment of different hallmarks of aging. However, these hallmarks of aging, including loss of proteostasis, mitochondrial dysfunction, and cellular senescence, are traditionally studied separately and leave the connections among these hallmarks largely un- known. With a growing understanding of these inter-organelle interactions within young cells, it has become of interest to explore how losses in compartmental crosstalk contribute to the age-associated degeneration of or- ganelle function and the establishment/connection of hallmarks of aging. We recently discovered an unexpected crosstalk between mitochondria and the lysosome (vacuole in yeast) that explains age-associated vacuole/lysosome de-acidification, a process conserved from yeast to human cells and which contributes to the loss of proteostasis during aging and in many age-related diseases. We found that mitochondria contribute to the acidification of lysosome/vacuole via membrane contact sites. Moreover, our pre- liminary studies suggest that the collapse of mitochondria-vacuole contact during the replicative aging of yeast causes age-dependent de-acidification of vacuole. Similarly, we observed a close correlation between mitochon- dria and lysosome acidification in cultured human cells and in C. elegans, suggesting evolutionary conservation of this process. To address how aging affects the mitochondria-lysosome/vacuole contact and whether this mi- tochondria-to-lysosome axis plays a critical role in lysosome acidification in cellular senescence and animals, we here propose to investigate the mitochondria-lysosome/vacuole contact and lysosome/vacuole acidification dur- ing aging and in different longevity paradigms. Specifically, we will combine the expertise of our different model systems to (1) dissect the mechanism(s) underlying the age-related loss of mitochondria-vacuole connection in yeast; (2) determine mitochondrial contribution to lysosome acidification in human cells; and (3) dissect the roles of mitochondria-lysosome connection in lysosome acidification in C. elegans. Our studies will investigate a novel, possibly evolutionarily conserved inter-organelle communication connect- ing mitochondrial dysfunction and lysosome/vacuole de-acidification across different organisms and longevity paradigms. Although traditional thinking has held that age-associated lysosome/vacuole dysfunction is respon- sible for inducing mitochondrial dysfunction in a uni-directional manner, our study will determine whether mito- chondrial dysfunction may conversely impact on lysosome/vacuole dysfunction during aging revealing a here- to-fore unappreciated two-way crosstalk between these tightly connected organelles which may together con- tribute to several important hallmarks of aging. As such, the long-term implications of this study could be the identification of novel conserved therapeutic targets for age-related diseases with lysosome defects.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Julie Kay Andersen其他文献

Julie Kay Andersen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Julie Kay Andersen', 18)}}的其他基金

Neuronal FXR as a potential therapeutic target for Alzheimer's disease
神经元 FXR 作为阿尔茨海默病的潜在治疗靶点
  • 批准号:
    10374862
  • 财政年份:
    2020
  • 资助金额:
    $ 48.5万
  • 项目类别:
Neuronal FXR as a potential therapeutic target for Alzheimer's disease
神经元 FXR 作为阿尔茨海默病的潜在治疗靶点
  • 批准号:
    10600989
  • 财政年份:
    2020
  • 资助金额:
    $ 48.5万
  • 项目类别:
Cellular senescence and Alzheimer's disease
细胞衰老和阿尔茨海默病
  • 批准号:
    10044328
  • 财政年份:
    2020
  • 资助金额:
    $ 48.5万
  • 项目类别:
Research Development Core
研究开发核心
  • 批准号:
    10649616
  • 财政年份:
    2020
  • 资助金额:
    $ 48.5万
  • 项目类别:
New mechanistic insights into how the gut metabolite urolithin A extends lifespan and prevents AD
关于肠道代谢物尿石素 A 如何延长寿命和预防 AD 的新机制见解
  • 批准号:
    10614896
  • 财政年份:
    2018
  • 资助金额:
    $ 48.5万
  • 项目类别:
Environmental exposure and astrocytic senescence: novel link to PD?
环境暴露和星形细胞衰老:与 PD 的新联系?
  • 批准号:
    8758627
  • 财政年份:
    2014
  • 资助金额:
    $ 48.5万
  • 项目类别:
2011 Oxidative Stress and Disease Gordon Research Conference
2011 氧化应激与疾病戈登研究会议
  • 批准号:
    8045654
  • 财政年份:
    2010
  • 资助金额:
    $ 48.5万
  • 项目类别:
2011 Oxidative Stress and Disease Gordon Research Conference
2011 氧化应激与疾病戈登研究会议
  • 批准号:
    8209520
  • 财政年份:
    2010
  • 资助金额:
    $ 48.5万
  • 项目类别:
2011 Oxidative Stress and Disease Gordon Research Conference
2011 氧化应激与疾病戈登研究会议
  • 批准号:
    8214198
  • 财政年份:
    2010
  • 资助金额:
    $ 48.5万
  • 项目类别:
Pharmacology of Lifespan Extension
延长寿命的药理学
  • 批准号:
    9521330
  • 财政年份:
    2008
  • 资助金额:
    $ 48.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 48.5万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.5万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 48.5万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 48.5万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 48.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 48.5万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 48.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了